Reader, if you are attracted to high yield but don't want to stay in the pure “beta” aspect of the big indices, the Fidelity Enhanced High Yield ETF (NYSEARCA: FDHY ) is an alternativeAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no ...

Group 1 - The Fidelity Enhanced High Yield ETF (NYSEARCA: FDHY) is presented as an alternative for investors seeking high yield without engaging in the "beta" aspect of major indices [1] - The article emphasizes that past performance does not guarantee future results, indicating a cautious approach to investment [2] - The article does not provide specific recommendations or advice regarding investment suitability for individual investors [2] Group 2 - The authors of the article are not licensed securities dealers or investment advisers, highlighting the independent nature of the analysis [2] - The article reflects the opinions of third-party authors, which may include both professional and individual investors [2] - There is no indication of any business relationship between the authors and the companies mentioned, ensuring objectivity in the analysis [1]

Group 1 - The article does not provide any specific content related to a company or industry [1]

Since my previous article , BHP (NYSE: BHP ) ( OTCPK:BHPLF ) had a total return of 14.8% versus the 11% of the S&P 500. This evolution, more than a speculative rally, was the confirmation thatI am an individual investor with over five years of experience in personal investing, holding a PhD in Economics from UCEMA. My investment approach focuses on value companies with solid long-term potential. I share my knowledge with the community by offering analysis to support individual investors. My articles reflect ...

Core Viewpoint - Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) is currently rated as a "Strong Buy" due to its recovery and growth trajectory after past misdeeds [1] Company Performance - The company has successfully navigated a decade since its share price collapse, leading to improved profitability and growth under current management [1]

Group 1 - The article does not provide any specific content or data related to a company or industry [1]

Group 1 - One IPO and four SPACs debuted this week, indicating a continued interest in public offerings and alternative investment vehicles [2] - Six IPOs and three SPACs submitted initial filings, suggesting a robust pipeline for future market activity [2] - Malaysian aquaculture company Megan Holdings (MGN) priced its US IPO at the low end of its range to raise $5 million, reflecting cautious investor sentiment [2]

Core Points - The event marks Harrow's inaugural Investor and Analyst Day, indicating a significant step in the company's engagement with investors and analysts [1] - The company will present for approximately 2.5 to 3 hours, followed by a 30-minute Q&A session, suggesting a structured approach to communication with stakeholders [4] Risks and Uncertainties - Harrow's forward-looking statements are subject to various risks and uncertainties, particularly regarding the commercial availability of FDA-approved products and the timely approval of certain drug candidates [2][3] - The company has outlined that these risks are detailed in its SEC filings, specifically in the Risk Factors section of its most recent annual report on Form 10-K and subsequent quarterly earnings reports on Form 10-Q [3]

The small-cap world is full of unique companies, and Revolve is surely one. Revolve has proven itself a success domestically, but the share price assumes international expansion is a sure thing. That growth hasn’t materialized yet. I think the companyI am an independent analyst and investor interested in investing at the intersection of value and growth. My method is a highly qualitative focus on mostly small caps, looking for both long term compounders as well as some special situations. On Twitter @Growth ...

Core Insights - Shares of Marriott Vacations Worldwide (NYSE: VAC) have underperformed over the past year, losing approximately 5% of their value due to a slower-than-expected turnaround [1] Company Performance - The turnaround process for Marriott Vacations Worldwide has taken longer than anticipated, contributing to the decline in share value [1] Analyst Perspective - The analysis reflects a contrarian investment approach based on macroeconomic views and specific stock turnaround stories aimed at achieving outsized returns with a favorable risk/reward profile [1]